Lenalidomide Sustained-release Tablets(Ac Pharma)

来那度胺缓释片（广州帝奇医药）

Report date: 2025/08/20 15:28:51

Base Information

Drug NameLenalidomide Sustained-release Tablets(Ac Pharma)
Drug Alias NameLenalidomidum那利度胺Lenalidomida雷利度胺Ladevina +[8] 
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCereblon modulatorsDNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders +[4] 
TargetsCereblonDNA-binding protein IkarosZinc finger protein Aiolos +[4] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesAc Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAc Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG